Clinical Trials Sponsored by Laboratoires Organon

Total 2761 results

Organon and Co

Terminated

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Asthma
Organon and Co

Completed

Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1) (ACT II)

Hypercholesterolemia
Organon and Co

Completed

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Psychosis
Organon and Co

Completed

Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

Pain
Organon and Co

Completed

Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)

Schizophrenia
Organon and Co

Completed

Obese Hypertension Study (0954-315)

Hypertension
Organon and Co

Completed

A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148) (COXIBUS)

Osteoarthritis
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

Contraception
Organon and Co

Completed

Survey of Osteoarthritis Real World Therapies (MK-0663-140) (SORT)

Osteoarthritis
Organon and Co

Completed

Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D

Osteoporosis
Organon and Co

Completed

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)

Schizophrenia
Organon and Co

Completed

A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)

Contraception
Organon and Co

Completed

Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)

Anovulation
Organon and Co

Completed

An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)

Contraception
Organon and Co

Completed

Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)

Schizophrenia | Bipolar Disorder
Organon and Co

Completed

Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885)

Breast Cancer | Climacteric Symptoms
Organon and Co

Completed

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

Contraception
Organon and Co

Completed

Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) (STEP)

Osteopenia
Organon and Co

Completed

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

Migraine Headache
Organon and Co

Withdrawn

An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

Infertility
Organon and Co

Completed

A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)

Osteoporosis
Organon and Co

Completed

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

Asthma
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Seasonal Allergic Rhinitis
Organon and Co

Completed

A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

Osteoporosis, Postmenopausal
Organon and Co

Completed

FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

Osteoporosis
Organon and Co

Completed

A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®) (TOTAL)

Menopause
Organon and Co

Completed

Tibolone Endometrium Study (Study 32972)(P06470) (THEBES)

Postmenopausal Women
Organon and Co

Completed

Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)

In Vitro Fertilization
Organon and Co

Completed

Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

Asthma
Organon and Co

Completed

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

Asthma, Exercise-Induced
Organon and Co

Completed

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

Rhinitis, Allergic, Seasonal | Asthma, Bronchial
Organon and Co

Completed

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Postmenopausal Osteoporosis
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

Migraine
Organon and Co

Completed

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

Asthma
Organon and Co

Completed

Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)

Respiratory Syncytial Virus Bronchiolitis
Organon and Co

Completed

Linear Growth Study (0476-097)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Acute Asthma (0476-322)

Asthma
Organon and Co

Completed

PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)

Bronchiolitis
Organon and Co

Completed

Montelukast Back to School Asthma Study (0476-340)

Asthma
Forest Laboratories
Mylan Laboratories

Terminated

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension

Hypertension

United States
Laboratoires Thea

Not yet recruiting

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Laboratoires Thea

Not yet recruiting

Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

Dry Eye Syndrome
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

United States, Colombia
Laboratoires Thea

Active, not recruiting

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension | Glaucoma

United States
Laboratoires Thea

Completed

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma
Laboratoires Vivacy

Completed

Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults

Aging | Skin Wrinkling

China

3

Subscribe